[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100502062":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":23,"locations":32,"responsibleParty":48,"collaborators":52,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":18,"maxAge":18,"enrollmentInfo":66,"targetDuration":18,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":18,"overallStatus":35,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":67},{"fullName":5,"class":6},"University of Maryland, Baltimore","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Enhanced Training on screening and treatment of HSIL (e-STH)","EXPERIMENTAL","Tailored training developed to overcome key barriers and promote facilitators unique to implementing HSIL screening and treatment. The development will be driven by the implementation science committee over 3 iterations every 4 months for up to a year to refine the adoption of strategies with the greatest breadth to facilitate implementation.",[13],"Behavioral: Enhanced Training on screening and treatment of HSIL (e-STH)",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Screening and treatment of HSIL","NO_INTERVENTION","The standard screening and treatment of HSIL outlined by the International Anal Neoplasia Society",null,[20],{"type":21,"name":9,"description":11,"armGroupLabels":22,"otherNames":18},"BEHAVIORAL",[9],[24,29],{"name":25,"role":26,"phone":27,"phoneExt":18,"email":28},"Rebecca Nowak, PhD","CONTACT","4107064642","rnowak@ihv.umaryland.edu",{"name":30,"role":26,"phone":18,"phoneExt":18,"email":31},"Sylvia Adebajo","SAdebajo@mgic.umaryland.edu",[33],{"facility":34,"status":35,"city":36,"state":18,"zip":18,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"International Center for Advocacy on Right to Health (ICARH)","RECRUITING","Abuja","Nigeria","NG",{"type":40,"coordinates":41},"Point",[42,43],7.49508,9.05785,{"lat":43,"lon":42},[46],{"name":47,"role":26,"phone":18,"phoneExt":18,"email":31},"Sylvia Adebajo, PhD",{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Rebecca Nowak","Assistant Professor",[53],{"name":54,"class":55},"National Cancer Institute (NCI)","NIH","100502062","implementation-of-anal-cancer-screening-and-treatment-in-nigeria-100502062",false,"NCT05817370","Implementation of Anal Cancer Screening and Treatment in Nigeria","Integrated Model for the Prevention of Anal Cancer Using Screen and Treat for High-grade Intraepithelial Lesions (IMPACT)","IMPACT","Inclusion Criteria:\n\n1. Possess a medical degree in medical sciences (MBBS or equivalent)\n2. At least 2-5 years of experience working with clinical HIV\u002FAIDS community\n3. Must be registered with the medical and dental council of Nigeria\n4. Possess a current medical practicing license\n5. Willing to work with the Sexual Gender Minority Community\n\nExclusion Criteria:",true,"ALL",{"count":67,"type":68},1,"ESTIMATED","INTERVENTIONAL",[71],"NA","The study is a feasibility pilot trial testing 2 types of training protocols on a single physician. The first training protocol is the current standard and was developed in high-income settings. The second training protocol will be developed so tailored to the Nigerian setting. Investigators will test if the physician performs differently in their ability to conduct anal cancer screening and treatment between the 2 training protocols.",[74],"Education, Medical","2025-06-21",{"date":77,"type":78},"2025-06-26","ACTUAL",{"date":80,"type":78},"2023-05-02",{"date":82,"type":68},"2027-08-31",{"name":5,"class":6}]